Ho-Chang Kuo Selected Research

Intravenous Immunoglobulins (IVIG)

2/2022	Near Infrared Spectroscopy Detects Change of Tissue Hemoglobin and Water Levelsin Kawasaki Disease and Coronary Artery Lesions.
1/2022	Multiple intravenous antibiotics usage is associated with intravenous immunoglobulin resistance in Kawasaki disease.
1/2022	Hydrogen Gas Inhalation Regressed Coronary Artery Aneurysm in Kawasaki Disease-Case Report and Article Review.
7/2021	Public Health Interventions for COVID-19 Reduce Kawasaki Disease in Taiwan.
3/2021	Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia.
1/2021	Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
1/2021	Cognitive development of children with Kawasaki disease and the parenting stress of their caregivers in Taiwan: a case-control study.
1/2021	Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin.
11/2020	Prognostic nutrition index as a predictor of coronary artery aneurysm in Kawasaki Disease.
1/2020	C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ho-Chang Kuo Research Topics

Disease

69	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 06/2022 - 06/2007
13	Fever (Fevers) 02/2022 - 10/2010
11	Infections 04/2022 - 12/2005
8	Asthma (Bronchial Asthma) 06/2021 - 01/2012
7	Inflammation (Inflammations) 01/2022 - 08/2012
7	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 01/2018
7	Anemia 01/2020 - 08/2012
6	COVID-19 04/2022 - 01/2021
6	Aneurysm (Aneurysms) 01/2022 - 01/2016
6	Hypersensitivity (Allergy) 01/2020 - 01/2009
5	Chronic Obstructive Pulmonary Disease (COPD) 03/2022 - 01/2015
4	Atopic Dermatitis (Atopic Eczema) 01/2022 - 12/2016
4	Vasculitis (Vasculitides) 01/2021 - 01/2016
4	Sepsis (Septicemia) 01/2020 - 08/2011
4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2019 - 02/2011
4	Communicable Diseases (Infectious Diseases) 01/2019 - 08/2007
4	Neoplasms (Cancer) 01/2017 - 03/2006
3	COVID-19 related pediatric multisystem inflammatory disease 04/2022 - 01/2021
2	Allergic Rhinitis 06/2021 - 12/2016
2	Shock 01/2021 - 04/2013
2	Coronary Aneurysm (Aneurysm, Coronary) 01/2021 - 01/2017
2	Hypoalbuminemia 01/2020 - 06/2007
2	Body Weight (Weight, Body) 07/2019 - 01/2017
2	Neurodevelopmental Disorders 10/2018 - 01/2018
2	Disease Susceptibility (Diathesis) 08/2017 - 01/2013
2	Lung Neoplasms (Lung Cancer) 05/2017 - 12/2011
2	Iron Deficiencies 04/2017 - 05/2016
2	Arteritis 01/2017 - 01/2012
2	Hypertension (High Blood Pressure) 04/2014 - 09/2013
2	Obstructive Jaundice (Cholestatic Jaundice) 01/2014 - 06/2012
2	Eosinophilia 12/2012 - 06/2007
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2012 - 12/2009
2	Reinfection 08/2011 - 04/2011
2	Severe Dengue 01/2011 - 08/2007
2	Dengue (Dengue Fever) 01/2011 - 08/2007
1	Dermatitis 03/2022
1	Stroke (Strokes) 01/2022

Drug/Important Bio-Agent (IBA)

40	Intravenous Immunoglobulins (IVIG)FDA Link 02/2022 - 06/2007
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2014
10	Immunoglobulin E (IgE)IBA 03/2022 - 08/2009
7	HepcidinsIBA 06/2022 - 06/2012
6	C-Reactive ProteinIBA 04/2022 - 10/2010
6	CytokinesIBA 01/2022 - 05/2009
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 04/2014
5	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2016
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2009
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2021 - 06/2014
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017 - 01/2014
4	Hemoglobins (Hemoglobin)IBA 06/2022 - 05/2016
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2012
4	Biological ProductsIBA 01/2022 - 09/2013
4	Interleukin-10 (Interleukin 10)IBA 10/2021 - 01/2012
4	AlbuminsIBA 01/2020 - 06/2007
4	MercuryIBA 01/2020 - 09/2013
4	Etanercept (Enbrel)FDA Link 10/2019 - 02/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 08/2007
3	Proteins (Proteins, Gene)FDA Link 10/2021 - 06/2018
3	Interleukin-17 (Interleukin 17)IBA 10/2021 - 01/2020
3	InterferonsIBA 10/2021 - 04/2016
3	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2014
3	GlucocorticoidsIBA 09/2016 - 01/2014
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2022 - 01/2014
2	ProcalcitoninIBA 04/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2022 - 12/2020
2	HydrogenIBA 01/2022 - 01/2021
2	Interferon-gamma (Interferon, gamma)IBA 10/2021 - 04/2016
2	Epidermal Growth Factor (EGF)IBA 10/2021 - 12/2011
2	Interleukin-5 (Interleukin 5)IBA 10/2021 - 12/2016
2	Monocyte Chemoattractant ProteinsIBA 10/2021 - 01/2012
2	InterleukinsIBA 10/2021 - 01/2012
2	montelukast (Singulair)FDA Link 06/2021 - 02/2012
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 02/2017
2	Blood Group Antigens (Blood Groups)IBA 01/2021 - 04/2013
2	Immunoglobulin M (IgM)IBA 01/2021 - 01/2020
2	AntioxidantsIBA 01/2021 - 04/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 12/2011
2	AllergensIBA 01/2020 - 08/2009
2	Hormones (Hormone)IBA 01/2019 - 06/2012
2	SmokeIBA 01/2019 - 01/2014
2	CadmiumIBA 10/2018 - 01/2016
2	Serum AlbuminIBA 06/2018 - 10/2010
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 09/2017 - 12/2014
2	Arginine (L-Arginine)FDA Link 01/2017 - 08/2014
2	IronIBA 05/2016 - 08/2012
2	MelatoninIBA 04/2014 - 01/2014
2	ClusterinIBA 01/2013 - 11/2010
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013 - 03/2012
2	Caspase 3 (Caspase-3)IBA 01/2013 - 02/2011
2	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2012 - 01/2011
2	CalciumIBA 12/2011 - 01/2011
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 03/2022
1	Heme Oxygenase-1IBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022

Therapy/Procedure

5	Therapeutics 01/2022 - 12/2009
3	Aftercare (After-Treatment) 01/2018 - 03/2006
2	General Anesthesia 09/2021 - 07/2016
2	Immunotherapy 01/2021 - 01/2021
1	Occupational Therapy (Therapy, Occupational) 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022